Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Prestige Consumer Healthcare Inc. (PBH : NYSE)

• Company Description    Prestige Consumer Healthcare Inc. and its subsidiaries develop, manufacture, market, sell and distributes over-the-counter (OTC) healthcare and household cleaning products in the U.S., Canada, Australia and other international markets. It provides its products to mass merchandisers as well as drug, food, dollar, convenience, club stores and e-commerce channel. It has two segments: North American OTC Healthcare and International OTC Healthcare. Some of the major brands include products like BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat treatments and mouth pain products, Clear Eyes eye care products, Compound Wwart removers, Dramamine Non-Drowsy naturals, Efferdent denture cleansers, Luden's throat drops, Hydralyte for oral rehydration, Fess nasal saline spray, Gaviscon for upset stomach remedies, etc. Its well-known acquisitions include Akorn Operating Company's consumer brands, Fleet, DenTek Holdings, Inc, Hydralyte and BC & Goody's. Number of Employees: 535

• Price / Volume Information    Yesterday's Closing Price: $56.27 Daily Weekly Monthly 20 Day Moving Average: 307,996 shares Shares Outstanding: 50.20 (millions) Market Capitalization: $2,824.71 (millions) Beta: 0.58 52 Week High: $63.83 52 Week Low: $49.09 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 6.25% 14.87% 12 Week -5.48% 4.04% Year To Date -7.22% 11.28%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 660 WHITE PLAINS ROAD SUITE 250 - TARRYTOWN,NY 10591 USA ph: 914-524-6800 fax: 302-674-5266 irinquiries@prestigebrands.com http://www.prestigebrands.com

• General Corporate Information    Officers Ronald M. Lombardi - President and Chief Executive Officer Christine Sacco - Chief Financial Officer John E. Byom - Director Celeste A. Clark - Director Christopher J. Coughlin - Director Peer Information Prestige Consumer Healthcare Inc. (LENXQ) Prestige Consumer Healthcare Inc. (CENT) Prestige Consumer Healthcare Inc. (FTDL) Prestige Consumer Healthcare Inc. (BTH) Prestige Consumer Healthcare Inc. (JAH) Prestige Consumer Healthcare Inc. (NHTC) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: CONSM PD-MISC DIS Sector: Consumer Discretionary CUSIP: 74112D101 SIC: 2834 Fiscal Year Fiscal Year End: March Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/04/22 Share - Related Items Shares Outstanding: 50.20 Most Recent Split Date: (:1) Beta: 0.58 Market Capitalization: $2,824.71 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $1.04 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $4.20 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 8.00% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/04/22

• Fundamental Ratios P/E Current FY Estimate: 13.38 Trailing 12 Months: 13.86 PEG Ratio: 1.67 Price Ratios Price/Book: 1.79 Price/Cash Flow: 11.64 Price / Sales: 2.60 EPS Growth vs. Year Ago Period: 15.19% vs. Previous Quarter: -8.08% Sales Growth vs. Year Ago Period: 12.27% vs. Previous Quarter: -2.74% ROE 03/31/22 - 13.82 12/31/21 - 13.90 09/30/21 - 13.71 ROA 03/31/22 - 5.67 12/31/21 - 5.58 09/30/21 - 5.39 Current Ratio 03/31/22 - 2.04 12/31/21 - 2.04 09/30/21 - 2.05 Quick Ratio 03/31/22 - 1.21 12/31/21 - 1.25 09/30/21 - 1.32 Operating Margin 03/31/22 - 18.99 12/31/21 - 18.90 09/30/21 - 18.65 Net Margin 03/31/22 - 18.90 12/31/21 - 17.85 09/30/21 - 17.56 Pre-Tax Margin 03/31/22 - 24.15 12/31/21 - 22.87 09/30/21 - 22.51 Book Value 03/31/22 - 31.43 12/31/21 - 30.25 09/30/21 - 29.17 Inventory Turnover 03/31/22 - 4.24 12/31/21 - 4.13 09/30/21 - 3.86 Debt-to-Equity 03/31/22 - 0.94 12/31/21 - 1.01 09/30/21 - 1.09 Debt-to-Capital 03/31/22 - 48.42 12/31/21 - 50.28 09/30/21 - 52.24

Powered by Zacks Investment Research ©